ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Conditional approval for Hansa's kidney transplant drug
August 27, 2020The EU Commission has granted conditional approval for use of Hansa Biopharma's Idefirix (imlifidase) to desensitise kidney transplant patients with a highly sensitised immune system. -
EMA recommends Idefirix (imlinfidase) is granted marketing authorisation
July 03, 2020The European Medicines Agency (EMA) recommended Idefirix is granted conditional marketing authorisation for highly sensitised patients awaiting kidney transplant.
Pharma Sources Insight January 2025
